
Develop More Products
DELEX plans to further develop and secure patent rights to more critical care and health care products. The new products will also enable DELEX to further expand its product offering and markets. DELEX currently has 5 company owned brands for global markets and 3 of which holds Intellectual Property Office of the Philippines (IPOPH) approved trademarks.
Secure More Product Distribution Rights
DELEX plans to secure distribution rights to more critical care and health care products. This will enable DELEX to expand its product offerings and markets that will include a range of products for critical care and for the treatment of major illnesses such as diabetes, heart, and Covid-related diseases. In addition to these products, healthcare solutions will also be developed for immunity and anti-aging, including stem cells and probiotics. Expanding our product range and coverage will enable DELEX to expand our markets and sales.